HORMONE RECEPTOR POSITIVE BREAST CANCER
Clinical trials for HORMONE RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian suppression plus tamoxifen: a Long-Term bet against breast cancer recurrence
Disease control Not yet recruitingThis study follows young women with hormone-sensitive breast cancer who stayed premenopausal or resumed menstruation after chemotherapy. Researchers are investigating whether adding two years of ovarian function suppression to standard tamoxifen therapy can lower the chance of ca…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Sponsor: MedicalExcellence • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Chemo-Free hope: new pill combo targets Hard-to-Treat breast cancer
Disease control Not yet recruitingThis study tests whether adding a new oral drug called fulvestaciclib to standard anti-HER2 and hormone therapy can help people with HR+/HER2+ advanced breast cancer live longer without their disease getting worse. Some participants receive the combo after initial chemotherapy, w…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a diabetes drug slow breast cancer growth?
Disease control Not yet recruitingThis phase 2 trial investigates whether tirzepatide, a drug used for weight loss and diabetes, can slow tumor growth in people with early-stage hormone-receptor-positive breast cancer. Participants receive tirzepatide alone, the standard hormone therapy letrozole alone, or both t…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Monthly vs. quarterly shots: can a simple switch boost ovarian suppression in young breast cancer?
Disease control Not yet recruitingThis Phase 2 trial will enroll 100 young women (ages 18-45) with hormone receptor-positive breast cancer who are already on a 3-month GnRH injection for ovarian suppression. Half will switch to a monthly injection, while the other half stays on the 3-month schedule. The study aim…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Virtual therapy may ease breast cancer treatment side effects
Symptom relief Not yet recruitingThis study tests a 6-session telehealth program called STRIDE, which uses cognitive behavioral therapy to help women with hormone-positive breast cancer manage side effects from adjuvant endocrine therapy. Participants will be randomly assigned to either the STRIDE program or usu…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Ear zaps may soothe painful side effect of breast cancer drugs
Symptom relief Not yet recruitingThis study tests whether a gentle electrical stimulation on the ear (called taVNS) can reduce joint and muscle pain caused by aromatase inhibitors, a common breast cancer treatment. 216 women with hormone-positive breast cancer will receive either real or sham stimulation daily f…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can acupuncture cool hot flashes in breast cancer survivors?
Symptom relief Not yet recruitingThis study tests whether acupuncture can safely reduce hot flashes in women with hormone receptor-positive breast cancer who are on hormone therapy. Sixty patients will receive either real or sham acupuncture three times a week for eight weeks, then be followed for 16 more weeks.…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can blood tests predict severe diarrhea from breast cancer drug?
Knowledge-focused Not yet recruitingThis study will enroll 235 women with hormone receptor-positive, HER2-negative breast cancer who are taking abemaciclib after surgery. Researchers want to see if higher levels of the drug in the blood are linked to severe diarrhea, a common side effect. By understanding this link…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE4 • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New tool could help breast cancer patients know their fertility future
Knowledge-focused Not yet recruitingThis observational study will follow 300 women aged 45-55 with hormone receptor-positive breast cancer to see if changes in a hormone called AMH can predict when they will reach menopause. Researchers will collect blood samples at seven time points and track menstrual patterns. T…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST CANCER
Sponsor: Shengjing Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC